|
SAP30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.96369603805624E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26120225374393E-11 |
| Normal-vs-Stage2 |
5.88499999842895E-08 |
| Normal-vs-Stage3 |
2.94849700210875E-11 |
| Normal-vs-Stage4 |
7.41609999965753E-07 |
| Stage1-vs-Stage2 |
6.822000E-01 |
| Stage1-vs-Stage3 |
6.621000E-01 |
| Stage1-vs-Stage4 |
1.704170E-01 |
| Stage2-vs-Stage3 |
9.287200E-01 |
| Stage2-vs-Stage4 |
4.798600E-01 |
| Stage3-vs-Stage4 |
3.506200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00179975426329E-10 |
| Normal-vs-AfricanAmerican |
1.210410E-04 |
| Normal-vs-Asian |
4.85300022390334E-10 |
| Caucasian-vs-AfricanAmerican |
3.809600E-01 |
| Caucasian-vs-Asian |
1.812790E-01 |
| AfricanAmerican-vs-Asian |
1.241350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.39466257723598E-12 |
| Normal-vs-Female |
4.05260269786822E-11 |
| Male-vs-Female |
9.361200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.57469592920734E-11 |
| Normal-vs-Age(41-60Yrs) |
9.10219677408008E-11 |
| Normal-vs-Age(61-80Yrs) |
4.25339985454798E-10 |
| Normal-vs-Age(81-100Yrs) |
1.021590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.793600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.581800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.305200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.886000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.864800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.352600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.414400E-01 |
| Classical-VS-Follicular |
5.126400E-01 |
| Classical-VS-Other |
6.985600E-01 |
| Classical-VS-Normal |
7.45490336129251E-11 |
| Tall-VS-Follicular |
6.624000E-01 |
| Tall-VS-Other |
6.609200E-01 |
| Tall-VS-Normal |
2.28590000261875E-08 |
| Follicular-VS-Other |
8.842000E-01 |
| Follicular-VS-Normal |
1.62290181293656E-11 |
| Other-VS-Normal |
1.998990E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.99760216648792E-15 |
| Normal-vs-N1 |
5.50599565940502E-11 |
| N0-vs-N1 |
4.862200E-01 |
|
|
